Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer

Gynecologic Oncology

Volumn 93, Issue 3, 2004, Pages 628-631

  Shimada, Muneaki ^a   Kigawa, Junzo ^a   Takahashi, Masakuni ^a   Minagawa, Yukihisa ^a   Okada, Makoto ^a   Kanamori, Yasunobu ^a   Itamochi, Hiroaki ^a   Oishi, Tetsuro ^a   Iba, Takahiro ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Prognostic factor; Radical surgery; Radiotherapy; Stromal invasion

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; STROMAL CELLS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 2942657542     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.03.011     Document Type: Article

References (23)

1. Chung C.K., Nahhas W.A., Stryker J.A., Curry S.L., Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am. J. Obstet. Gynecol. 33:1980;550-556
2. FIGO annual report on the results of treatment in gynecological cancer. Int. J. Gynaecol. Obstet. 36:1991;39. [Suppl.]
3. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.B., et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 76:1995;1948-1955
4. FIGO annual report on the results of treatment in gynecological cancer. J. Epidemiol. Biostat. 6:2001;26-31
5. Brewster W.R., Monk B.J., Ziogas A., Anton-Culver H., Yamada D., Berman M.L. Intent to treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995. Obstet. Gynecol. 97:2001;248-254
6. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 350:1997;535-540
7. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., Akazawa K., et al. Multivariate analysis of the histopathologic prognosis factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186
8. Delgado G., Bundy B.N., Fowler W.C. Jr., Stehman F.B., Sevin B., Creasman W.T., et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix; a Gynecologic Oncology Group Study. Gynecol. Oncol. 35:1989;314-320
9. Rotman M., John M., Boyce J. Prognostic factors in cervical carcinomas: implications in staging and management. Cancer. 48:1981;560-567
10. Monk B.J., Cha D.S., Walker J.L., Burger R.A., Ramsinghani N.S., Manetta A., et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol. Oncol. 54:1994;4-9
11. Russell A.H., Tong D.Y., Figge D.C., Tamimi H.K., Greer B.E., Elder S.J. Adjuvant postoperative pelvic radiation for carcinoma of the uterine cervix: pattern of cancer recurrence in patients undergoing elective radiation following radical hysterectomy and pelvic lymphadectomy. Int. J. Radiat. Oncol. Biol. Phys. 10:1984;211-214
12. Kinney W.K., Alvarez R.D., Reid G.C. Value of adjuvant whole pelvis irradiation after Wertheim hysterectomy for early stage squamous carcinoma of the cervix with pelvic nodal metastasis. A matched control study. Gynecol. Oncol. 34:1989;258-262
13. Alexander S., Brian N.B., Marvin Z.R., Samuel S.L., Laila I.M., Richard J.Z. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol. Oncol. 73:1999;177-183
14. Takamura A., Mizoe J., Arimoto T., Kamada T., Shirato H., Matsuoka Y. Is adjuvant radiotherapy beneficial in the management of stage I-II squamous cell carcinoma of the uterine cervix with negative metastatic nodes and positive parametrial involvement? A retrospective review of 70 patients. Asia-Oceania J. Obstet. Gynaecol. 19:1993;145-151
15. Inoue T. Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension, and cell types. A study of 628 cases with stage IB, IIA, and IIB cervical carcinoma. Cancer. 54:1984;3035-3042
16. Okada M., Kigawa J., Minagawa Y., Kanamori Y., Shimada M., Takahashi M., et al. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer. Gynecol. Oncol. 70:1998;61-64
17. Piver M.S., Rultledge F., Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet. Gynecol. 44:1974;265-272
18. Peters W.A. III, Liu P.Y., Barrett R.J. V, Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18:2000;1606-1613
19. Fioricca J.V., Roberts W.S., Greenberg H., Hoffman M.S., Lapolla J.P., Cavanagh D. Morbidity and survival patterns in patients after radical hysterectomy and postoperative adjuvant pelvic radiotherapy. Gynecol. Oncol. 36:1990;343-347
20. Grigsby P.W., Herzog T.J. Current Management of patients with invasive cervical carcinoma. Clin. Obstet. Gynecol. 44:2001;531-537
21. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. III, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340:1999;1154-1161
22. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340:1999;1137-1143
23. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340:1999;1144-1153